DigitalBridge (DBRG) Upgraded to Buy: What Does It Mean for the Stock? — Positive

DBRG   Zacks Investment Research — June 12, 2025

DigitalBridge (DBRG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news DigitalBridge (DBRG) Upgraded to Buy: What Does It Mean for the Stock?

Dollar General (DG) Upgraded to Buy: What Does It Mean for the Stock? — Positive

DG   Zacks Investment Research — June 12, 2025

Dollar General (DG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Dollar General (DG) Upgraded to Buy: What Does It Mean for the Stock?

All You Need to Know About Ingredion (INGR) Rating Upgrade to Buy — Positive

INGR   Zacks Investment Research — June 12, 2025

Ingredion (INGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news All You Need to Know About Ingredion (INGR) Rating Upgrade to Buy

All You Need to Know About Samsara Inc. (IOT) Rating Upgrade to Buy — Positive

IOT   Zacks Investment Research — June 12, 2025

Samsara Inc. (IOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news All You Need to Know About Samsara Inc. (IOT) Rating Upgrade to Buy

Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock? — Positive

MBOT   Zacks Investment Research — June 12, 2025

Microbot Medical (MBOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock?

Here's Why Cameco (CCJ) is a Great Momentum Stock to Buy — Positive

CCJ   Zacks Investment Research — June 12, 2025

Does Cameco (CCJ) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Here's Why Cameco (CCJ) is a Great Momentum Stock to Buy

Cameco (CCJ) Moves to Buy: Rationale Behind the Upgrade — Positive

CCJ   Zacks Investment Research — June 12, 2025

Cameco (CCJ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news Cameco (CCJ) Moves to Buy: Rationale Behind the Upgrade

Are You Looking for a Top Momentum Pick? Why AngloGold Ashanti (AU) is a Great Choice — Positive

AU   Zacks Investment Research — June 12, 2025

Does AngloGold Ashanti (AU) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Are You Looking for a Top Momentum Pick? Why AngloGold Ashanti (AU) is a Great Choice

Here's Why KB Financial (KB) is a Great Momentum Stock to Buy — Positive

KB   Zacks Investment Research — June 12, 2025

Does KB Financial (KB) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Here's Why KB Financial (KB) is a Great Momentum Stock to Buy

Buy MARA Holdings For Its Bitcoin And Get The Mining Business 'For Free' — Positive

MARA   Seeking Alpha — June 12, 2025

MARA's market cap is nearly matched by its $5.42 billion Bitcoin holdings, meaning investors value the mining business at a discount. MARA's mining operation, adds more value annually in Bitcoin to the balance sheet than what the market appears to be valuing it. Investors can capture upside through new BTC mined monthly, valuation expansion in the mining business, or a BTC rally boosting existing BTC holdings.

image for news Buy MARA Holdings For Its Bitcoin And Get The Mining Business 'For Free'

OPEC's Moment of Truth Is Coming — Neutral

BNO  DBO  GUSH  IEO  OIH  OIL  PXJ  UCO  USO  XOP   Barrons — June 12, 2025

The group's production decisions have confused the oil market. We will soon know how deep the cartel plans to dig in, Ben Cahill writes in a guest commentary.

image for news OPEC's Moment of Truth Is Coming

The success of Circle should lead to more crypto IPOs later this year. The contenders include Gemini, Kraken, OpenSea, and Ripple.

image for news Circle Stock Went Gangbusters. Crypto IPOs Are the Next Big Thing.

BOCA RATON, FL, June 12, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first U.S. public company with a treasury strategy built to accumulate and compound Solana (“SOL”), announced today it will host a live Twitter Spaces event on Monday, June 16, 2025 at 1:00 PM ET to walk investors through the company's recent S-1 filings, its newly announced $5 billion Equity Line of Credit (ELOC), and broader public market capital strategy.

image for news DeFi Development Corp. to Host Twitter Spaces Explaining ELOCs, S-1s, and Capital Strategy

RESTON, Va. , June 12, 2025 /PRNewswire/ -- Every day, Leidos (NYSE: LDOS) employees tackle customers' most vexing challenges in defense, homeland security, information technology, intelligence, health, energy, and more.

image for news Leidos Welcomes Nearly 900 Summer Interns from 290 Colleges and Universities

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Petco Health and Wellness Company, Inc. ("Petco") (NASDAQ:WOOF) concerning possible violations of federal securities laws. Petco issued a press release on June 5, 2025, reporting its financial results for the first quarter of 2025.

image for news Levi & Korsinsky Investigates Petco Health And Wellness Company, Inc. (WOOF) Over Potential Securities Fraud Allegations

The FDA has approved AbbVie's RINVOQ (upadacitinib) for the treatment of giant cell arteritis, making it the ninth approved indication for the drug. This also marks the first time an oral JAK inhibitor has been approved for this prevalent form of vasculitis in Western countries. RINVOQ's approval has sparked competition among other pharmaceutical companies in the giant cell arteritis market. The FDA has approved AbbVie's RINVOQ (upadacitinib) for the treatment of giant cell arteritis, making it the ninth approved indication for the drug. This also marks the first time an oral JAK inhibitor has been approved for this prevalent form …

image for news Giant-Cell Arteritis Market Heats up with AbbVie's RINVOQ Approval | DelveInsight

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”). Rocket Pharmaceuticals is a fully integrated, late-stage biotechnology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.

image for news Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Short Seller Says AppLovin Is 'Desperate And Doomed,' Shares Slide — Negative

APP   Benzinga — June 12, 2025

Applovin Corp APP is in the crosshairs of short sellers again.

image for news Short Seller Says AppLovin Is 'Desperate And Doomed,' Shares Slide

BALTIMORE--(BUSINESS WIRE)--Sinclair today announced record-breaking growth, best-season-to-date ratings, and premium programming acquisitions across its free, over-the-air multicast networks, CHARGE, Comet, ROAR and The Nest. The networks posted gains fueled by several strategic initiatives, including the acquisition of anchor series, expanded distribution in top 10 DMA markets, rebranding of TBD to ROAR, strategic programming decisions, and successful fan-focused, multi-platform events includ.

image for news Sinclair's Multicast Networks CHARGE, Comet, ROAR and The Nest Announce Record Breaking Growth and New Programming Acquisitions

Zimbabwe's export ban could reshape global lithium supply chain — Neutral

PLL   Proactive Investors — June 12, 2025

If Zimbabwe's government gets its way, from January 2027 no raw lithium concentrate will be allowed to leave the country. For miners and battery manufacturers, that's a big deal, and not just because Zimbabwe is the world's second-largest exporter of spodumene to China.

image for news Zimbabwe's export ban could reshape global lithium supply chain